Bayer breaks ground on German cell and gene therapy centre
Once completed, the Berlin site will also be the new home for one of the company’s Bayer Co. Lab start-up incubators.
List view / Grid view
Once completed, the Berlin site will also be the new home for one of the company’s Bayer Co. Lab start-up incubators.
Winners of this year's awards will be revealed during the opening of CPHI Frankfurt 2025.
The German pharma company will create over 200 jobs at its new Blarney site in Cork.
The new $5 billion manufacturing site is set to become the company’s first integrated facility for API and drug product manufacturing.
The company’s investment strategy will also encompass AI, digital technology and supply chain infrastructure.
The novel approach could enhance quality testing applications in pharmaceutical manufacturing.
The October event at Messe Frankfurt is expected to welcome more than 63,000 pharmaceutical professionals.
Says the Bay Area building’s digital infrastructure will make it one of biopharma’s leading artificial intelligence-powered centres.
Significant investment in advanced technologies Is expected to support global adoption of mass spectrometry in the next five years.
European Parliament's SANT Committee urges for greater control on medicine provisions to help strengthen security of supply.
2 September 2025 | By FUJIFILM Wako Europe GmbH
Join this webinar to find out how RT-rt PCR is revolutionising sterility testing and discover a unique approach that provides reliable one-day results and enhanced sensitivity and detection capabilities.
The University of Cambridge and A*STAR platform aims to enhance fault detection, system monitoring and predictive maintenance.
EASYGEN is supported by EU funding andindustry partners that include Fresenius, Charles River, Cellix, Pro-Liance and TQ Therapeutics.
Contracts to use a facility at Fujifilm’s North Carolina site as part of moves to onshore its manufacturing.
22 August 2025 | By US Pharmacopeia
Join our live webinar with USP as they explore new approaches for impurity profiling - unveiling new frameworks, analytical tools, and regulatory insights that are reshaping pharmaceutical quality standards.